impax laboratories inc (IPXL:NASDAQ GS)
Earnings & Estimates Summary - IMPAX LABORATORIES INC (IPXL)
2013 revenues at Impax Laboratories Inc. totaled $511.5M USD, while annual earnings equaled $0.82 per share.
Quarterly Earnings & Estimates - IMPAX LABORATORIES INC (IPXL)
Impax Laboratories Inc.'s Quarterly Earnings
Impax Laboratories Inc. reported 2nd quarter 2014 earnings of $0.60 per share on 08/8/2014.
Annual Earnings & Estimates - IMPAX LABORATORIES INC (IPXL)
Impax Laboratories Inc.'s Annual Earnings
Impax Laboratories Inc. reported annual 2013 earnings of $0.82 per share on 02/22/2014.
Quarterly Revenues - IMPAX LABORATORIES INC (IPXL)
Impax Laboratories Inc.'s Quarterly Revenues
Impax Laboratories Inc. had 2nd quarter 2014 revenues of $188.1M USD. This bettered the $159.9M USD consensus of the 13 analysts covering the company. This was 45.1% above the prior year's 2nd quarter results.
Annual Revenues - IMPAX LABORATORIES INC (IPXL)
Impax Laboratories Inc.'s Annual Revenues
Impax Laboratories Inc. had revenues for the full year 2013 of $511.5M USD. This was -12.1% below the prior year's results.
|Acorda Therapeutics Inc||$38.47 USD||+0.22|
|Emergent Biosolutions Inc||$27.11 USD||+1.20|
|Lannett Co Inc||$43.91 USD||+1.21|
|Nektar Therapeutics||$15.21 USD||+0.74|
|Sagent Pharmaceuticals Inc||$24.04 USD||-1.88|
|View Industry Companies|